Wednesday, November 18, 2020 9:46:47 PM
https://www.otcmarkets.com/stock/ONPH/news/Oncology-Pharma-Announces-Extension-of-Letter-of-Intent-with-Kalos-Therapeutics-Retained-an-Interim-CEO-and-Approval-of-?id=272181
Now this company ValiRx announces a deal with Kalos.
https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=3837634&lang=en-GB&companycode=uk-azh&v=
Is license expiring and is ValiRx replacing ONPH as Kalos partner?
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM